Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 949-955

Spandidos Publications

Access to resources Recommend Favorite

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

By Cheng Jing  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite

Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer

By De Petris Luigi   Lax Ingmar   Sirzén Florin   Friesland Signe  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 375-381

Humana Press, Inc

Access to resources Recommend Favorite

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

By Oka M.   Fukuda M.   Fukuda M.   Kinoshita A.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Takatani H.   Narasaki F.   Nagashima S.   Nakamura Y.-I.   Hayashi N.   Kohno S.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1359-1365

Elsevier

Access to resources Recommend Favorite

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401

By Takayama Koichi   Inoue Koji   Tokunaga Shoji   Matsumoto Takemasa   Oshima Tsukasa   Kawasaki Masayuki   Imanaga Tomotoshi   Kuba Mutsuo   Takeshita Masafumi   Harada Taishi   Shioyama Yoshiyuki   Nakanishi Yoichi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1353-1359

Springer Publishing Company

Access to resources Recommend Favorite